Diagnosing, treating and managing breast cancer during COVID-19

COVID-19: Using oncology drugs and surgery during the coronavirus pandemic

COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic

Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?

Treatment of cancer patients during the COVID-19 pandemic in the Philippines

Economic and research benefits of the AORTIC meeting

Managing toxicities associated with immune-checkpoint inhibitors

Conducting Oncology Clinical Trials in Africa II: Strategies for Building Needed Research Infrastructure for Clinical Trials

COVID-19: Managing paediatric patients under the COVID pandemic

Conducting Oncology Clinical Trials in Africa II: Innovative recruitment methods for oncology clinical trials

Meet the Expert: Dr Bodour Salhia

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma